Overview: Victoza Solution for Injection is a glucagon-like peptide-1 (GLP-1) receptor agonist used to manage type 2 diabetes. It contains Liraglutide, which helps to lower blood sugar by increasing insulin secretion, decreasing glucagon levels, and slowing gastric emptying. Key Benefits: – Effective blood sugar control – Reduces risk of cardiovascular events – May aid in weight loss Composition: Liraglutide (6mg/ml) How It Works: Liraglutide mimics the GLP-1 hormone, enhancing insulin secretion only when needed and suppressing glucagon release, thereby improving glycemic control. Usage Instructions: – Inject once daily, at any time of the day, independent of meals – Administer subcutaneously in the abdomen, thigh, or upper arm – Follow the prescribed dosage and duration Side Effects: – Nausea or vomiting – Constipation or diarrhea – Low blood sugar (especially with other anti-diabetics) Precautions: – Not for use in type 1 diabetes or DKA – Caution in patients with a history of thyroid tumors – Avoid during pregnancy or breastfeeding unless advised by doctor Storage Instructions: – Store in a refrigerator (2 – 8°C) – Do not freeze Manufacturer: Novo Nordisk India Pvt Ltd Disclaimer: This content is for informational purposes only. Please consult your healthcare provider before using any medication.